The legacy of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in sales , its intellectual property lapse created a deluge of lower-priced alternatives , significantly eroding its position . While some firms may attempt to capitalize on male sexual dysfunction, the c